Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study

(2016) Elliot B. Tapper et al.   Clinical Gastroenterology and Hepatology

Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis

(2016) Fasiha Kanwal et al.   HEPATOLOGY

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

(2016) Jérôme Boursier et al.   HEPATOLOGY

Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation

(2016) S Banerjee et al.   Mucosal Immunology

Review article: the antimicrobial effects of rifaximin on the gut microbiota

(2015) H. L. DuPont   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease

(2015) G. Vassallo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

(2015) A. Wieland et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Inflammation, Psychiatric Symptoms, and Opioid Use Are Associated With Pain and Disability in Patients With Cirrhosis

(2015) Shari S. Rogal et al.   Clinical Gastroenterology and Hepatology

Decompensated cirrhosis and microbiome interpretation

(2015) Jasmohan S. Bajaj et al.   NATURE

Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization

(2015) Jingjing Meng et al.   Scientific Reports

Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?

(2015) Debbie L Shawcross   Expert Review of Gastroenterology & Hepatology

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

(2015) Jasmohan S. Bajaj et al.   Scientific Reports

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Review article: prescribing medications in patients with cirrhosis - a practical guide

(2013) J. H. Lewis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pain and Opioid Use in Chronic Liver Disease

(2013) Shari S. Rogal et al.   DIGESTIVE DISEASES AND SCIENCES

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

(2013) Morgan G I Langille et al.   NATURE BIOTECHNOLOGY

Pseudomonas aeruginosa Virulence Expression Is Directly Activated by Morphine and Is Capable of Causing Lethal Gut-Derived Sepsis in Mice During Chronic Morphine Administration

(2011) Trissa Babrowski et al.   ANNALS OF SURGERY

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing

(2010) Patrick Gillevet et al.   CHEMISTRY & BIODIVERSITY

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

(2008) Roger K. Verbeeck   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis

(2008) Puneeta Tandon et al.   SEMINARS IN LIVER DISEASE